Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | May 19, 2023 | May 23, 2023 |
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | Director | February 01, 2013 | February 05, 2013 |
| LABCORP HOLDINGS INC.LH · Entity 1277 | Director | February 06, 2024 | February 08, 2024 |
| Tenaya Therapeutics, Inc.TNYA · Entity 6506 | Director | May 28, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 19, 2023 · Filed May 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,240 |
Reported balance
After 2023-05-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-19 · Grant · Acquired 939 · Balance 6,240 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
BRISTOL MYERS SQUIBB CO
Report date February 01, 2013 · Filed February 05, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 48,335.71 |
Reported balance
After 2013-02-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2013-02-01 · Grant · Acquired 4,364 · Balance 48,335.71 F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
LABCORP HOLDINGS INC.
Report date February 06, 2024 · Filed February 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,120 |
Reported balance
After 2024-02-07 transaction · row 1
1 source rowRow 1 · 2024-02-07 · Exercise / conversion · Acquired 947 · Balance 8,120 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,183 |
Reported balance
After 2024-02-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-02-06 · Grant · Acquired 236 · Balance 1,183 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2: The Restricted Stock Units vest fully on February 6, 2025. F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 98 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 236 |
Reported balance
After 2024-02-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-02-07 · Exercise / conversion · Disposed 947 · Balance 236 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4: The Restricted Stock Units vested fully on February 7, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest fully on February 6, 2025.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 98 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc.
F4: The Restricted Stock Units vested fully on February 7, 2024.
Tenaya Therapeutics, Inc.
Report date May 28, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2036-05-27 | Direct | 120,000 |
Reported balance
After 2026-05-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 120,000 · Balance 120,000 F1: Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2019 Filed Feb 14, 2019 21:18 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 1,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005996 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 15:00 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 350 | $162.14 | $56,749.00 |
DisclosureSEC source: 0001127602-18-034638 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,886 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| April 27, 2018 Filed May 1, 2018 22:57 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015831 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,136 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 14:15 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005651 · form4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,038 Underlying: Common Stock · 1,038 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2019. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:57 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004897 · form4.xml · derivative · entry 2 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:57 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004897 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionNon-qualified Stock Options · Derivative | 3,100 | $0.00 Strike: $77.19 | $0.00 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · derivative · entry 6 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,100 shares Expires 2020-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 11 | $156.92 | $1,726.12 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 5 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,973 Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 8 | $156.91 | $1,255.28 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 4 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,984 Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 2,881 | $156.90 | $452,020.55 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 3 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,992 Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 200 | $156.68 | $31,336.26 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 2 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,873 Read SEC document |
| August 11, 2017 Filed Aug 15, 2017 19:03 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 3,100 | $77.19 | $239,289.00 |
DisclosureSEC source: 0001127602-17-025632 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2017 Filed May 4, 2017 00:42 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016745 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 18:58 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 1,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005293 · form4.xml · derivative · entry 2 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,263 Underlying: Common Stock · 1,560 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 9, 2017. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 9, 2017. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 18:58 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 1,560 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-005293 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2017 Filed Feb 9, 2017 19:15 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-004716 · form4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823 Underlying: Common Stock · 1,263 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 7, 2018. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| May 03, 2016 Filed May 6, 2016 00:13 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-051284 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,779 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| April 24, 2015 Filed Apr 28, 2015 23:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-015465 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| October 30, 2014 Filed Oct 31, 2014 20:16 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-030662 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:19 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002986 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,335.71 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2012 Filed Feb 3, 2012 21:33 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 4,313 | $32.46 | $139,999.98 |
DisclosureSEC source: 0001225208-12-003080 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,285.91 Underlying: Common Stock, $0.10 par value · 4,313 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 4,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-004713 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,342.73 Underlying: Common Stock, $0.10 par value · 4,935 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2010 Filed Jan 4, 2011 19:41 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 506.69 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-000487 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,003.82 Underlying: Common Stock, $0.10 par value · 506.69 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2010 Filed Oct 4, 2010 20:10 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 492.58 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-021990 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,141.47 Underlying: Common Stock, $0.10 par value · 492.58 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2010 Filed Jul 2, 2010 20:38 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 537.93 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-016522 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,280.73 Underlying: Common Stock, $0.10 par value · 537.93 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2010 Filed Apr 2, 2010 18:23 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 506.12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-009609 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,383.09 Underlying: Common Stock, $0.10 par value · 506.12 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2010 Filed Feb 2, 2010 18:31 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 4,490 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-003018 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,575.45 Underlying: Common Stock, $0.10 par value · 4,490 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted on a 1 for 1 basis into a share of common stock. Directors will receive shares upon settlement. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2009 Filed Jan 5, 2010 21:11 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 569.07 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-000626 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,085.45 Underlying: Common Stock, $0.10 par value · 569.07 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2009 Filed Oct 2, 2009 17:29 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 553.59 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-019891 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,201.67 Underlying: Common Stock, $0.10 par value · 553.59 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2009 Filed Jul 2, 2009 20:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 611.55 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-015041 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,345.93 Underlying: Common Stock, $0.10 par value · 611.55 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2009 Filed Apr 2, 2009 15:04 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 578.71 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-009470 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,405.94 Underlying: Common Stock, $0.10 par value · 578.71 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 02, 2009 Filed Feb 26, 2009 16:55 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 5,093 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004963 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,827.23 Underlying: Common Stock, $0.10 par value · 5,093 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 22:07 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 542.77 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-000505 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,530.05 Underlying: Common Stock, $0.10 par value · 542.77 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2008 Filed Oct 2, 2008 19:06 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 661.12 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-015559 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,781.39 Underlying: Common Stock, $0.10 par value · 661.12 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2008 Filed Jul 2, 2008 20:45 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 756.09 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-011380 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,159.14 Underlying: Common Stock, $0.10 par value · 756.09 shares Expires not disclosed F1 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2008 Filed Jul 17, 2008 21:31 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 1,528.31 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-08-012139 · doc4a.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,931.36 Underlying: Common Stock, $0.10 par value · 1,528.31 shares Expires not disclosed F1 · security: This Form 4 is being amended to correct the number of deferred share units that were acquired on June 30, 2008. F2 · derivative.exercise_price: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F3 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 20:42 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 632.02 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-08-000131 · wil855.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,248.68 Underlying: Common Stock, $0.10 par value · 632.02 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2008 Filed Feb 5, 2008 21:27 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 4,648 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-08-000048 · wil793.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,616.66 Underlying: Common Stock, $0.10 par value · 4,648 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 22:08 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 441.78 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-08-000013 · wil774.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,794.66 Underlying: Common Stock, $0.10 par value · 441.78 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 21:05 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 375.78 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000201 · wil762.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,302.87 Underlying: Common Stock, $0.10 par value · 375.78 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 20:05 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 407.69 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000165 · wil746.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,878.99 Underlying: Common Stock, $0.10 par value · 407.69 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 29, 2007 Filed Jan 29, 2008 22:00 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 502.69 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-08-000028 · wil781.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,973.99 Underlying: Common Stock, $0.10 par value · 502.69 shares Expires not disclosed F1 · shares: This form is being amended to correct the number of deferred share units accrued as of June 2007. F2 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F3 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 30, 2007 Filed Apr 3, 2007 19:47 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 427.78 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000102 · wil696.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,428.64 Underlying: Common Stock, $0.10 par value · 427.78 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 21:45 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 3,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000045 · wil652.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000.86 Underlying: Common Stock, $0.10 par value · 3,500 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 20:19 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 404.45 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000014 · wil640.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496.08 Underlying: Common Stock, $0.10 par value · 404.45 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 29, 2006 Filed Oct 3, 2006 21:06 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantDeferred Share Units · Derivative | 90.6 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-06-000211 · wil619.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90.6 Underlying: Common Stock, $0.10 par value · 90.6 shares Expires not disclosed F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.